The Adaptation of MCF-7 Breast Cancer Spheroids to the Chemotherapeutic Doxorubicin: The Dynamic Role of Phase I Drug Metabolizing Enzymes
<b>Background/Objectives:</b> Drug resistance (DR) is a major challenge in cancer therapy, contributing to approximately 90% of cancer-related deaths. While alterations in drug metabolism are known to be key drivers of DR, their role—particularly in the early stages of acquired chemoresi...
Saved in:
| Main Authors: | Daniel Crispim, Carolina Ramos, Francisco Esteves, Michel Kranendonk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/2/136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of circulating biomarkers in a rat model of doxorubicin-induced cardiotoxicity
by: Emilia ANCA, et al.
Published: (2024-12-01) -
Activities of cytochrome P450 enzyme CYP102A16 from Bacillus sp. C3
by: LI Ze-li, et al.
Published: (2012-11-01) -
Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice
by: V. V. Smirnov, et al.
Published: (2018-02-01) -
Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy
by: Ke Wang, et al.
Published: (2024-12-01) -
Expression profiles of CYP1A1 and CYP1B1 enzymes in Non-small Cell Lung Cancer of Turkish Patients
by: H. Bayram, et al.
Published: (2025-03-01)